Through research collaborations with the University of Michigan and Cedars-Sinai Medical Center, we funded patient-derived cellular disease modeling and high-throughput therapeutic screening for neurodegenerative diseases. Made grants totaling $76,959 for ALS research including drug screening in patient-derived neurons.